Yu Huiqing, Tian Ling, Yang Liejun, Liu Shihong, Wang Sixiong, Gong Juan
Department of Palliative Medicine, Chongqing University Cancer Hospital, Chongqing, China.
Front Oncol. 2021 Mar 19;11:620213. doi: 10.3389/fonc.2021.620213. eCollection 2021.
Non-small cell lung cancer (NSCLC) is a frequently diagnosed aggressive cancer all over the world. Small nucleolar RNAs (snoRNAs) are a group of non-coding mediatory RNAs. A previous report indicated that small nucleolar RNA 47 (SNORA47) is upregulated in NSCLC. However, the role of SNORA47 in NSCLC is unclear.
Cell proliferation was measured by immunofluorescence staining. Cell apoptosis and cycle of NSCLC were tested by flow cytometry and the protein expressions were investigated by Western-blot. Meanwhile, cell migration and invasion were detected by transwell assay. Xenograft mice model was established to detect the effect of SNORA47 knockdown on tumor growth of NSLC .
Knockdown of SNORA47 significantly inhibited the proliferation of NSCLC cells inducing cell apoptosis. Moreover, migration and invasion of NSCLC cells were notably decreased by SNORA47 shRNA. SNORA47 knockdown significantly induced G1 arrest in NSCLC cells regulation of p27 Kip1, CDK2, and cyclin D1. Meanwhile, SNORA47 shRNA inhibited EMT process and PI3K/Akt signaling in NSCLC cells. Finally, silencing of SNORA47 significantly inhibited the tumor growth of NSCLC .
Knockdown of SNORA47 significantly inhibited the tumorigenesis of NSCLC inhibition of PI3K/Akt signaling and EMT process. Thereby, our finding might shed a new light on exploring the strategies for the treatment of NSCLC.
非小细胞肺癌(NSCLC)是全球常见的侵袭性癌症。小核仁RNA(snoRNAs)是一类非编码介导RNA。先前的一份报告表明,小核仁RNA 47(SNORA47)在NSCLC中上调。然而,SNORA47在NSCLC中的作用尚不清楚。
通过免疫荧光染色测量细胞增殖。通过流式细胞术检测NSCLC的细胞凋亡和周期,并通过蛋白质印迹法研究蛋白质表达。同时,通过Transwell实验检测细胞迁移和侵袭。建立异种移植小鼠模型以检测敲低SNORA47对NSLC肿瘤生长的影响。
敲低SNORA47显著抑制NSCLC细胞增殖并诱导细胞凋亡。此外,SNORA47 shRNA显著降低了NSCLC细胞的迁移和侵袭。敲低SNORA47显著诱导NSCLC细胞G1期阻滞,调节p27 Kip1、CDK2和细胞周期蛋白D1。同时,SNORA47 shRNA抑制NSCLC细胞的EMT过程和PI3K/Akt信号通路。最后,沉默SNORA47显著抑制NSCLC的肿瘤生长。
敲低SNORA47显著抑制NSCLC的肿瘤发生,抑制PI3K/Akt信号通路和EMT过程。因此,我们的发现可能为探索NSCLC的治疗策略提供新的思路。